Clinical and Translational Nutrition
Jeannette Beasley, PhD
Associate Professor
New York University
New York, New York, United States
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Elaine DeLeon, MD, MHS (she/her/hers)
Clinical Assistant Professor, Departments of Medicine and Population Health
NYU Grossman School of Medicine
New York, New York, United States
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Stephanie Fitzpatrick, PhD
Professor
Northwell Health
Portland, Oregon, United States
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Margrethe Horlyck-Romanovsky, DrPH (she/her/hers)
Assistant Professor
Health and Nutrition Sciences
City University of New York, Brooklyn College
Brooklyn, New York, United States
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Emily Johnston, PhD, MPH, RDN, CDCES (she/her/hers)
Research Assistant Professor, Department of Medicine
NYU Grossman School of Medicine
New York, New York, United States
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
More than one-third of adults in the United States have prediabetes, but fewer than one-fifth are diagnosed. Since the seminal Diabetes Prevention Program (DPP) was established as efficacious in 2002, the intervention has been implemented in hospital, community, work, and other settings. Despite having an efficacious behavioral lifestyle program, the prevalence of prediabetes has increased by almost 5% in past decade, and an estimated 30% of adults are undiagnosed. Only ~600,000 of the 96 million adults (0.6%) with diagnosed prediabetes had enrolled in the National DPP as of April 2022. This session will discuss approaches for reducing barriers to accessing the DPP using multi-level approaches in diverse populations. Speakers will review additional supports provided to adapt the program to the differing needs of programs delivered in the healthcare system as well as through community-based programs. Discussion will inform best practices for increasing uptake of the program to improve diabetes prevention.
Chair: Jeannette M. Beasley, PhD – New York University
Speaker: Stephanie L. Fitzpatrick, PhD – Northwell Health
Speaker: Margrethe F. Horlyck-Romanovsky, DrPH (she/her/hers) – City University of New York, Brooklyn College
Speaker: Emily A. Johnston, PhD, MPH, RDN, CDCES (she/her/hers) – NYU Grossman School of Medicine
Speaker: Elaine DeLeon, MD, MHS (she/her/hers) – NYU Grossman School of Medicine
Chair: Jeannette M. Beasley, PhD – New York University
Speaker: Stephanie L. Fitzpatrick, PhD – Northwell Health
Speaker: Margrethe F. Horlyck-Romanovsky, DrPH (she/her/hers) – City University of New York, Brooklyn College
Speaker: Emily A. Johnston, PhD, MPH, RDN, CDCES (she/her/hers) – NYU Grossman School of Medicine
Speaker: Elaine DeLeon, MD, MHS (she/her/hers) – NYU Grossman School of Medicine